Cell and gene therapies offer great opportunities for potentially treating a wide range of diseases, including cancer, osteoarthritis, diabetes, and various genetic disorders. Cell therapy involves the transfer of intact, live cells into a patient to treat or alleviate disease symptoms, while gene therapy requires modification or manipulation of gene expression to alter the properties of cells for therapeutic use.
Over the past decade, we have seen the emergence of new cell and gene-based therapies utilizing innovative technologies. For example, advances in gene editing technologies and vector delivery systems have enabled the development of more personalized treatment approaches, while innovations in the structure and manufacturing of CAR-T cells have resulted in significant improvements in treatment efficacy and persistence.
To discover more about this exciting area of research, explore our collection of on-demand webinars, application notes, and whitepapers which highlight key developments in the field and where the future of cell and gene therapies is headed.
In this on-demand webinar, two leading scientists Khalid Shah, MS, PhD at Harvard Medical School and Arun Srivastava, PhD at University of Florida College of Medicine discussed gene edited and engineered cell therapy for cancer as well as next generation of AAV vectors for human gene therapy.
What is the future for cell and gene therapies? Watch our on-demand webinar where expert presenters Arun Srivastava, PhD, Professor of Genetics at University of Florida and at Sunil Chada PhD, President at DNASolve Biopharma Consulting provided perspectives on how the gene therapy field ought to evolve.
What does it take to innovate successfully in the field of gene therapies? Learn from leading experts, Roland W. Herzog, PhD at Indiana University School of Medicine and Nagendra Chemuturi, PhD at Takeda Pharmaceuticals in this on-demand webinar.
Discover our eBook which showcases a collection of cell and gene therapy application notes to support your cell and gene therapy workflows.
As the number of cell and gene therapy applications grows, so does the requirement for the monitoring of Critical Quality Attributes (CQAs) during viral vector characterization. Analytical tools are essential for this to be done accurately, leading to the development of high quality and safe products.
We’ve identified four key pillars to achieve this and have solutions to support you through the whole process.
In recent years, investigators have worked tirelessly to solve many of the fundamental challenges associated with cell and gene therapies. Yet, innovation and success are an evolving process that address challenges faced during the drug discovery and development stages.
PerkinElmer discussed next-generation cancer therapies with one of the founders of the field, Dr. Sunil Chada, download the whitepaper to learn more.
Oncology researchers have taken gene-editing to the next level, developing tumor biology-driven cell therapies and testing them on preclinical models that depict human tumors and their microenvironments. Read our whitepaper to learn from Khalid Shah, MS, PhD, Director, Center for Stem Cell Therapeutics and Imaging, BWH-Harvard Medical School about novel therapeutic offerings that help cancer patients live a better quality of life.
Download this complete industry report to learn more about the gene therapy market trends and latest advances.
Discover this original infographic for in-depth insight into new gene therapy breakthroughs and techniques.